logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hiroaki Okamoto

yokohama municipal citizen’s hospital
H指数:34
被引数:4,816

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of vulnerability on concurrent chemoradiotherapy outcomes in patients with locally advanced non-small cell lung cancer using an integrated clinical trial database

使用整合的临床试验数据库研究脆弱性对局部晚期非小细胞肺癌患者同步放化疗结局的影响

Therapeutic Advances in Medical Oncology
IF4.2
2026-01-170
PRE
Kenji Morimoto; Tadaaki Yamada; Naoya Nishioka; Nobuyuki Yamamoto; Seiji Niho; Isamu Okamoto; Katsuyuki Hotta; Hiroaki Okamoto; Shunichi Sugawara; Toshio Shimokawa; Yuichi Ozawa; Satoshi Oizumi; Koichi Takayama
Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529)
RADIATION ONCOLOGY
IF3.2
2025-01-040
OAAI
Tokito, Takaaki; Yamada, Kazuhiko; Ishii, Hidenobu; Takiguchi, Yuichi; Saito, Go; Minato, Koichi; Imai, Hisao; Tanaka, Hiroshi; Miura, Satoru; Watanabe, Kageaki; Koreeda, Yoshifusa; Ono, Akira; Furuya, Naoki; Misumi, Toshihiro; Hayakawa, Kazushige; Ogo, Etsuyo; Okamoto, Hiroaki
Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab-ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial
LANCET RESPIRATORY MEDICINE
IF32.8
2024-11-011
PRE
Shiraishi, Yoshimasa; Nomura, Shogo; Sugawara, Shunichi; Horinouchi, Hidehito; Yoneshima, Yasuto; Hayashi, Hidetoshi; Azuma, Koichi; Hara, Satoshi; Niho, Seiji; Morita, Ryo; Yamaguchi, Masafumi; Yokoyama, Toshihide; Yoh, Kiyotaka; Kurata, Takayasu; Okamoto, Hiroaki; Okamoto, Masaki; Kijima, Takashi; Kasahara, Kazuo; Fujiwara, Yutaka; Murakami, Shuji; Kanda, Shintaro; Akamatsu, Hiroaki; Takemoto, Shinnosuke; Kaneda, Hiroyasu; Kozuki, Toshiyuki; Ando, Masahiko; Sekino, Yuta; Fukuda, Haruhiko; Ohe, Yuichiro; Okamoto, Isamu
Biomarker analysis of plasma samples in YAMATO study: A randomized phase II trial comparing switching treatment of osimertinib following 8 months of afatinib (A) and osimertinib alone (B) in untreated advanced NSCLC patients with common EGFR mutation (TORG1939/WJOG12919L)

YAMATO研究中的血浆样本生物标志物分析：一项比较在携带常见EGFR突变（TORG1939/WJOG12919L）的未经治疗晚期NSCLC患者中，接受阿法替尼（A）治疗8个月后换用奥希替尼与单独使用奥希替尼（B）的随机II期试验。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Yoshioka, H.; Nakamura, A.; Sakai, K.; Nishio, K.; Yonesaka, K.; Misumi, T.; Yokoyama, T.; Itani, H.; Tachihara, M.; Kanemura, H.; Akamatsu, H.; Ono, A.; Ishikawa, H.; Yamamoto, N.; Okamoto, H.; Kurata, T.
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
TARGETED ONCOLOGY
IF4
2024-04-133
OAAI
Nishioka, Naoya; Imai, Hisao; Endo, Masahiro; Notsu, Akifumi; Doshita, Kosei; Igawa, Satoshi; Yokouchi, Hiroshi; Ninomiya, Takashi; Tokito, Takaaki; Soda, Sayo; Fujiwara, Takasato; Asao, Tetsuhiko; Nakamichi, Shinji; Kawamura, Takahisa; Inomata, Minehiko; Nakashima, Kazuhisa; Ito, Kentaro; Goto, Yasuhiro; Umeda, Yukihiro; Hirai, Soichi; Ushio, Ryota; Yokoo, Keiki; Takeda, Takayuki; Fukui, Tomoya; Ishihara, Masashi; Osaki, Takashi; Kubo, Sousuke; Fujiwara, Takumi; Yamamoto, Chie; Tsuda, Takeshi; Tamura, Nobumasa; Hosokawa, Shinobu; Chihara, Yusuke; Ikeda, Satoshi; Furuya, Naoki; Nakahara, Yoshiro; Miura, Satoru; Okamoto, Hiroaki
Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis

尼达尼布联合化疗治疗小细胞肺癌合并特发性肺纤维化

ANNALS OF THE AMERICAN THORACIC SOCIETY
IF5.4
2024-04-014
PRE
Ikeda, Satoshi; Ogura, Takashi; Kato, Terufumi; Kenmotsu, Hirotsugu; Agemi, Yoko; Tokito, Takaaki; Ito, Kentaro; Isomoto, Kohsuke; Takiguchi, Yuichi; Yoneshima, Yasuto; Yokoyama, Toshihide; Harada, Toshiyuki; Tanzawa, Shigeru; Kobayashi, Nobuaki; Iwasawa, Tae; Misumi, Toshihiro; Okamoto, Hiroaki
A Phase Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell Lung Cancer: TORG2241 (UBE-Q)
CLINICAL LUNG CANCER
IF3.3
2024-01-011
OAAI
Nakamichi, Shinji; Kubota, Kaoru; Matsuyama, Kotone; Misumi, Toshihiro; Kozuki, Toshiyuki; Sugawara, Shunichi; Naoki, Katsuhiko; Kobayashi, Nobuaki; Shukuya, Takehito; Shimokawa, Tsuneo; Ishihara, Masashi; Wakui, Hiroshi; Hosomi, Yukio; Tanaka, Hiroshi; Saito, Haruhiro; Hosokawa, Shinobu; Takiguchi, Yuichi; Kasai, Takashi; Nokihara, Hiroshi; Morita, Ryo; Aono, Hiromi; Furuya, Naoki; Okamoto, Hiroaki
OSIRAM-1: A multicenter, open label, randomized phase II study of osimertinib plus ramucirumab versus osimertinib alone as initial chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer (TORG1833)
ANNALS OF ONCOLOGY
IF65.4
2023-10-012
PRE
Nakahara, Y.; Kato, T.; Isomura, R.; Misumi, T.; Tamiya, M.; Yoh, K.; Furuya, N.; Ono, A.; Takiguchi, Y.; Koyama, K.; Ikeda, S.; Watanabe, K.; Tokito, T.; Seki, N.; Imai, H.; Shukuya, T.; Shibata, Y.; Hosokawa, S.; Kozuki, T.; Okamoto, H.

研究方向

暂未获取到该数据
T
Tsuneo Shimokawa
H 指数:11论文数:105被引数:438
T
Terufumi Kato
H 指数:58论文数:521被引数:2.9万
S
Satoshi Ikeda
H 指数:29论文数:386被引数:3,595
Y
Yuki Misumi
H 指数:9论文数:72被引数:258
Y
Yoko Agemi
H 指数:8论文数:38被引数:254
T
Toshihiro Misumi
H 指数:20论文数:323被引数:2,466
Y
Yuri Taniguchi
H 指数:8论文数:67被引数:177
T
Takeharu Yamanaka
H 指数:68论文数:587被引数:2.0万
Y
Yuichi Takiguchi
H 指数:47论文数:415被引数:9,049
Y
Yukio Hosomi
H 指数:34论文数:388被引数:9,223